<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02975011</url>
  </required_header>
  <id_info>
    <org_study_id>JS-CT-2016-03</org_study_id>
    <nct_id>NCT02975011</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety of Korean Medicine for Lumbar Stenosis Patients With Sciatica</brief_title>
  <official_title>Observational Study on the Effectiveness and Safety of Integrative Korean Medicine Treatment for Patients With Sciatica Due to Lumbar Stenosis: Multicenter, Prospective, Single Group Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jaseng Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jaseng Medical Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective study investigating the effectiveness and safety in lumbar stenosis patients
      receiving integrative Korean medicine treatment at 3 locations of Jaseng Hospital of Korean
      Medicine through assessment of pain, functional disability, and quality of life
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective study to the aim of investigating the effectiveness and safety in
      patients with neurogenic claudication diagnosed as lumbar stenosis by lumbar MRI and
      receiving integrative Korean medicine treatment (herbal medicine, Chuna manipulation, bee
      venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, and cupping) at
      3 locations of Jaseng Hospital of Korean Medicine (Bucheon, Daejeon, Busan (Haeundae))
      through assessment of pain, functional disability, and quality of life with 1-year follow-up
      period
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Numeric rating scale (NRS) of low back pain</measure>
    <time_frame>Change from baseline to 3 months</time_frame>
    <description>Change in low back pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Numeric rating scale (NRS) of radiating leg pain</measure>
    <time_frame>Change from baseline to 3 months</time_frame>
    <description>Change in radiating leg pain intensity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric rating scale (NRS) of low back pain</measure>
    <time_frame>Baseline, 1, 2, 3, 6, 12 months</time_frame>
    <description>Low back pain intensity for the past 3 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric rating scale (NRS) of radiating leg pain</measure>
    <time_frame>Baseline, 1, 2, 3, 6, 12 months</time_frame>
    <description>Radiating leg pain intensity for the past 3 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index (ODI)</measure>
    <time_frame>Baseline, 1, 2, 3, 6, 12 months</time_frame>
    <description>Functional disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol 5-dimensions 5-levels (EQ-5D-5L)</measure>
    <time_frame>Baseline, 1, 2, 3, 6, 12 months</time_frame>
    <description>Health-related quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change (PGIC)</measure>
    <time_frame>6, 12 months</time_frame>
    <description>Global patient-reported outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current medical service use</measure>
    <time_frame>Baseline, 1, 2, 3, 6, 12 months</time_frame>
    <description>Current use of medical services (type, frequency, period)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-free walking time</measure>
    <time_frame>Baseline, 1, 2, 3, 6, 12 months</time_frame>
    <description>Average pain-free walking time for the past 3 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical examination</measure>
    <time_frame>Baseline, 1, 2, 3 months</time_frame>
    <description>Lumbar physical examination</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Lumbar Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
    <description>Lumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Herbal medicine</intervention_name>
    <description>Herbal medicine will be administered in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
    <other_name>Traditional herbal medicine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chuna manipulation</intervention_name>
    <description>Chuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered to pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
    <other_name>Chuna spinal manipulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bee venom pharmacopuncture</intervention_name>
    <description>Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
    <other_name>Bee venom acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pharmacopuncture</intervention_name>
    <description>Pharmacopuncture consisting of select herbal ingredients will be administered at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electroacupuncture</intervention_name>
    <description>Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cupping</intervention_name>
    <description>Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Other intervention(s)</intervention_name>
    <description>Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.</description>
    <arm_group_label>Lumbar stenosis group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Lumbar stenosis patients with MRI results visiting and receiving treatment at 3 locations
        of Jaseng Hospital of Korean Medicine between November 2016 and March 2018
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with radiating leg pain with or without low back pain (LBP) (walking pain NRS
             ≥4)

          -  Patients with dural sac cross-sectional area (DSCA) of &lt;100 mm2 or morphological
             grading ≥B as assessed on MRI

          -  Patients with clear neurogenic claudication symptoms (symptoms aggravated with
             walking, and alleviated upon resting in lumbar flexion position)

          -  Patients who have received surgery recommendation for lumbar spinal stenosis

          -  Patients with plans of receiving Korean medicine treatment for lumbar spinal stenosis
             for ≥2 months

          -  Patients who have agreed to study participation

        Exclusion Criteria:

          -  Patients with vascular claudication

          -  Patients with other systemic diseases that may interfere with treatment effect or
             outcome interpretation

          -  Patients with soft tissue pathologies or pathologies of non-spinal origin that may
             cause LBP or radiating leg pain (e.g. spinal tumor, rheumatoid arthritis)

          -  Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g.
             hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine
             intake, serious diabetes with risk of infection, severe cardiovascular diseases, or
             other conditions deemed unsuitable for acupuncture treatment)

          -  Pregnant patients or patients planning pregnancy

          -  Patients with serious psychological disorders

          -  Patients unable to fill out study participation consent form

          -  Subjects deemed unsuitable for study participation as assessed by the researchers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinho Lee, KMD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jaseng Medical Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>In-Hyuk Ha, KMD, M.Sc.</last_name>
    <phone>+82-2-3218-2188</phone>
    <email>hanihata@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jaseng Medical Foundation</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In-Hyuk Ha, KMD</last_name>
    </contact>
    <investigator>
      <last_name>Joowon Kim, KMD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haechan Jeong, KMD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Min-young Kim, KMD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2016</study_first_submitted>
  <study_first_submitted_qc>November 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2016</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jaseng Medical Foundation</investigator_affiliation>
    <investigator_full_name>Jinho Lee</investigator_full_name>
    <investigator_title>Medical management director</investigator_title>
  </responsible_party>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Patient Satisfaction</keyword>
  <keyword>Numeric Rating Scale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Sciatica</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

